Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246.
Gorgoulis, Vassilis G
AffiliationLaboratory of Human Carcinogenesis, NCI-CCR, National Institutes of Health, Bethesda, 20892-4258, MD, USA
MetadataShow full item record
AbstractTP53 mutants (mutp53) are involved in the pathogenesis of most human cancers. Specific mutp53 proteins gain oncogenic functions (GOFs) distinct from the tumor suppressor activity of the wild-type protein. Tumor-associated macrophages (TAMs), a hallmark of solid tumors, are typically correlated with poor prognosis. Here, we report a non-cell-autonomous mechanism, whereby human mutp53 cancer cells reprogram macrophages to a tumor supportive and anti-inflammatory state. The colon cancer cells harboring GOF mutp53 selectively shed miR-1246-enriched exosomes. Uptake of these exosomes by neighboring macrophages triggers their miR-1246-dependent reprogramming into a cancer-promoting state. Mutp53-reprogammed TAMs favor anti-inflammatory immunosuppression with increased activity of TGF-β. These findings, associated with poor survival in colon cancer patients, strongly support a microenvironmental GOF role for mutp53 in actively engaging the immune system to promote cancer progression and metastasis.
CitationMutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246. 2018, 9(1): 771 Nat Commun
- BAG2 promotes tumorigenesis through enhancing mutant p53 protein levels and function.
- Authors: Yue X, Zhao Y, Liu J, Zhang C, Yu H, Wang J, Zheng T, Liu L, Li J, Feng Z, Hu W
- Issue date: 2015 Aug 13
- Exosomal microRNAs derived from colon cancer cells promote tumor progression by suppressing fibroblast TP53 expression.
- Authors: Yoshii S, Hayashi Y, Iijima H, Inoue T, Kimura K, Sakatani A, Nagai K, Fujinaga T, Hiyama S, Kodama T, Shinzaki S, Tsujii Y, Watabe K, Takehara T
- Issue date: 2019 Aug
- Pontin, a new mutant p53-binding protein, promotes gain-of-function of mutant p53.
- Authors: Zhao Y, Zhang C, Yue X, Li X, Liu J, Yu H, Belyi VA, Yang Q, Feng Z, Hu W
- Issue date: 2015 Nov
- Gain-of-function miRNA signature by mutant p53 associates with poor cancer outcome.
- Authors: Zhang Y, Hu Y, Fang JY, Xu J
- Issue date: 2016 Mar 8
- The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins.
- Authors: Wei S, Wang H, Lu C, Malmut S, Zhang J, Ren S, Yu G, Wang W, Tang DD, Yan C
- Issue date: 2014 Mar 28